| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $609.3M | +5.3% | +7.9% |
| R&D Expense | $50.5M | -83.2% | — |
| SG&A Expense | $118.7M | -34.0% | +109.3% |
| Operating Income | $427.2M | +103.6% | -41.9% |
| Pre-tax Income | $444.2M | +390.1% | -44.9% |
| Income Tax | $0 | — | — |
| Net Income | $288.2M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $938.9M | +48.6% | -1.2% |
| Current Assets | $1.85B | +21.7% | +3.1% |
| Total Assets | $19.35B | +5.6% | +7.2% |
| Current Liabilities | $530.8M | -56.0% | -54.5% |
| Long-term Debt | $8.95B | +11.8% | +17.6% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $1.66B | — | — |
| Investing Cash Flow | -$766.4M | — | — |
| Financing Cash Flow | -$886.4M | — | — |
| -47.0% |
| EPS (Basic) | $0.67 | +857.1% | -45.1% |
| EPS (Diluted) | $0.67 | +857.1% | -44.6% |
| $9.73B |
| +10.3% |
| +25.0% |
| Stockholders' Equity | $9.62B | +1.2% | -6.2% |